Artemisinin-based combination therapies (ACTs) are the cornerstone of treatment for uncomplicated Plasmodium falciparum malaria. Each regimen combines a fast-acting artemisinin derivative with a ...

Partial resistance to artemisinin, the recommended treatment for Plasmodium falciparum malaria, occurred in Ugandan children with severe disease who were treated with the drug, and some treated ...

Mutations in malarial parasites linked to artemisinin-resistance in Southeast Asia have now been found in African children hospitalized for complicated malaria, according to a new study presented at ...

Mutations in malarial parasites linked to artemisinin-resistance in Southeast Asia have now been found in African children hospitalised for complicated malaria, according to a new study presented at ...

RGCB study reveals host biology influences malaria treatment failures, suggesting new strategies to enhance drug efficacy and ...

Artemisinin derivatives remain the most rapid‐acting antimalarials for treating Plasmodium falciparum infection. Resistance has emerged through multiple interconnected mechanisms. Central among these ...

Indiana University School of Medicine researchers, in collaboration with colleagues at Makerere University in Uganda, have uncovered evidence of partial resistance to artemisinin derivatives - the ...

Drug-resistant malaria threatens global control efforts, especially in India, highlighting the urgent need for innovative ...